Jay Montgomery

13PUBLICATIONS
35CO-AUTHORS
Biologically active moleculesCardiology (incl. cardiovascular diseases)Molecular imaging (incl. electron microscopy and neutron diffraction)Predictive and prognostic markersElectrical energy generation (incl. renewables, excl. photovoltaics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 25, 2025
2-Hydroxybenzylamine for Treatment of Atrial Fibrillation: A First-in-Human Clinical Pilot Trial.

Zachary T Yoneda, Matthew O'Neill, Diane M Crawford

|Nov 19, 2024
Risk Prediction in Non-Ischemic Cardiomyoapthy.

Jay A Montgomery, Gregory G Jackson

|May 28, 2024
Can Intracardiac Echocardiography Reduce Steam Pops During Half-Normal Saline Irrigated Radiofrequency Ablation?

Kanae Hasegawa, Zachary T Yoneda, Jose R Martines-Parachini

|Mar 12, 2024
Recurrence After Atrial Fibrillation Ablation and Investigational Biomarkers of Cardiac Remodeling.

Majd A El-Harasis, Joseph A Quintana, J Roberto Martinez-Parachini

|Feb 17, 2024
Safety of ventricular arrhythmia radiofrequency ablation with half-normal saline irrigation.

Kanae Hasegawa, Zachary T Yoneda, Edward M Powers

|Sep 27, 2022
A Mechanistic Clinical Trial Using (<i>R</i>)- Versus <i>(S</i>)-Propafenone to Test RyR2 (Ryanodine Receptor) Inhibition for the Prevention of Atrial Fibrillation Induction.

M Benjamin Shoemaker, Zachary T Yoneda, Diane M Crawford

Pageof 3